Top Key Companies for CRISPR Cas9 Market: Horizon Discovery Group, Editas Medicine, Agilent Technologies, Cellecta, Thermo Fisher Scientific, Intellia Therapeutics, GenScript, Merck, CRISPR Therapeutics, Mirus Bio, Integrated DNA Technologies (IDT), Takara Bio, Caribou Biosciences, GeneCopoeia.
Global CRISPR Cas9 Market Research Report: 2023-2030 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global CRISPR Cas9 Market Overview And Scope:
The Global CRISPR Cas9 Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of CRISPR Cas9 utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global CRISPR Cas9 Market Segmentation
By Type, CRISPR Cas9 market has been segmented into:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Application, CRISPR Cas9 market has been segmented into:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Regional Analysis of CRISPR Cas9 Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of CRISPR Cas9 Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The CRISPR Cas9 market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the CRISPR Cas9 market.
Top Key Companies Covered in CRISPR Cas9 market are:
Horizon Discovery Group
Editas Medicine
Agilent Technologies
Cellecta
Thermo Fisher Scientific
Intellia Therapeutics
GenScript
Merck
CRISPR Therapeutics
Mirus Bio
Integrated DNA Technologies (IDT)
Takara Bio
Caribou Biosciences
GeneCopoeia
Key Questions answered in the CRISPR Cas9 Market Report:
1. What is the expected CRISPR Cas9 Market size during the forecast period, 2022-2028?
2. Which region is the largest market for the CRISPR Cas9 Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the CRISPR Cas9 Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the CRISPR Cas9 Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key CRISPR Cas9 companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the CRISPR Cas9 Markets?
7. How is the funding and investment landscape in the CRISPR Cas9 Market?
8. Which are the leading consortiums and associations in the CRISPR Cas9 Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: CRISPR Cas9 Market by Type
5.1 CRISPR Cas9 Market Overview Snapshot and Growth Engine
5.2 CRISPR Cas9 Market Overview
5.3 Genome Editing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Genome Editing: Geographic Segmentation
5.4 Genetic engineering
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Genetic engineering: Geographic Segmentation
5.5 gRNA Database/Gene Librar
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 gRNA Database/Gene Librar: Geographic Segmentation
5.6 CRISPR Plasmid
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 CRISPR Plasmid: Geographic Segmentation
5.7 Human Stem Cells
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2030F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Human Stem Cells: Geographic Segmentation
5.8 Genetically Modified Organisms/Crops
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2016-2030F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Genetically Modified Organisms/Crops: Geographic Segmentation
5.9 Cell Line Engineering
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2016-2030F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Cell Line Engineering: Geographic Segmentation
Chapter 6: CRISPR Cas9 Market by Application
6.1 CRISPR Cas9 Market Overview Snapshot and Growth Engine
6.2 CRISPR Cas9 Market Overview
6.3 Biotechnology Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Biotechnology Companies: Geographic Segmentation
6.4 Pharmaceutical Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical Companies: Geographic Segmentation
6.5 Academic Institutes
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic Institutes: Geographic Segmentation
6.6 Research and Development Institutes
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Research and Development Institutes: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 CRISPR Cas9 Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 CRISPR Cas9 Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 CRISPR Cas9 Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 HORIZON DISCOVERY GROUP
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 EDITAS MEDICINE
7.4 AGILENT TECHNOLOGIES
7.5 CELLECTA
7.6 THERMO FISHER SCIENTIFIC
7.7 INTELLIA THERAPEUTICS
7.8 GENSCRIPT
7.9 MERCK
7.10 CRISPR THERAPEUTICS
7.11 MIRUS BIO
7.12 INTEGRATED DNA TECHNOLOGIES (IDT)
7.13 TAKARA BIO
7.14 CARIBOU BIOSCIENCES
7.15 GENECOPOEIA
Chapter 8: Global CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Genome Editing
8.2.2 Genetic engineering
8.2.3 gRNA Database/Gene Librar
8.2.4 CRISPR Plasmid
8.2.5 Human Stem Cells
8.2.6 Genetically Modified Organisms/Crops
8.2.7 Cell Line Engineering
8.3 Historic and Forecasted Market Size By Application
8.3.1 Biotechnology Companies
8.3.2 Pharmaceutical Companies
8.3.3 Academic Institutes
8.3.4 Research and Development Institutes
Chapter 9: North America CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Genome Editing
9.4.2 Genetic engineering
9.4.3 gRNA Database/Gene Librar
9.4.4 CRISPR Plasmid
9.4.5 Human Stem Cells
9.4.6 Genetically Modified Organisms/Crops
9.4.7 Cell Line Engineering
9.5 Historic and Forecasted Market Size By Application
9.5.1 Biotechnology Companies
9.5.2 Pharmaceutical Companies
9.5.3 Academic Institutes
9.5.4 Research and Development Institutes
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Genome Editing
10.4.2 Genetic engineering
10.4.3 gRNA Database/Gene Librar
10.4.4 CRISPR Plasmid
10.4.5 Human Stem Cells
10.4.6 Genetically Modified Organisms/Crops
10.4.7 Cell Line Engineering
10.5 Historic and Forecasted Market Size By Application
10.5.1 Biotechnology Companies
10.5.2 Pharmaceutical Companies
10.5.3 Academic Institutes
10.5.4 Research and Development Institutes
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Genome Editing
11.4.2 Genetic engineering
11.4.3 gRNA Database/Gene Librar
11.4.4 CRISPR Plasmid
11.4.5 Human Stem Cells
11.4.6 Genetically Modified Organisms/Crops
11.4.7 Cell Line Engineering
11.5 Historic and Forecasted Market Size By Application
11.5.1 Biotechnology Companies
11.5.2 Pharmaceutical Companies
11.5.3 Academic Institutes
11.5.4 Research and Development Institutes
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Genome Editing
12.4.2 Genetic engineering
12.4.3 gRNA Database/Gene Librar
12.4.4 CRISPR Plasmid
12.4.5 Human Stem Cells
12.4.6 Genetically Modified Organisms/Crops
12.4.7 Cell Line Engineering
12.5 Historic and Forecasted Market Size By Application
12.5.1 Biotechnology Companies
12.5.2 Pharmaceutical Companies
12.5.3 Academic Institutes
12.5.4 Research and Development Institutes
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Genome Editing
13.4.2 Genetic engineering
13.4.3 gRNA Database/Gene Librar
13.4.4 CRISPR Plasmid
13.4.5 Human Stem Cells
13.4.6 Genetically Modified Organisms/Crops
13.4.7 Cell Line Engineering
13.5 Historic and Forecasted Market Size By Application
13.5.1 Biotechnology Companies
13.5.2 Pharmaceutical Companies
13.5.3 Academic Institutes
13.5.4 Research and Development Institutes
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America CRISPR Cas9 Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Genome Editing
14.4.2 Genetic engineering
14.4.3 gRNA Database/Gene Librar
14.4.4 CRISPR Plasmid
14.4.5 Human Stem Cells
14.4.6 Genetically Modified Organisms/Crops
14.4.7 Cell Line Engineering
14.5 Historic and Forecasted Market Size By Application
14.5.1 Biotechnology Companies
14.5.2 Pharmaceutical Companies
14.5.3 Academic Institutes
14.5.4 Research and Development Institutes
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
CRISPR Cas9 Scope:
Report Data
|
CRISPR Cas9 Market
|
CRISPR Cas9 Market Size in 2022
|
USD XXX million
|
CRISPR Cas9 CAGR 2023 - 2030
|
XX%
|
CRISPR Cas9 Base Year
|
2022
|
CRISPR Cas9 Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
Horizon Discovery Group, Editas Medicine, Agilent Technologies, Cellecta, Thermo Fisher Scientific, Intellia Therapeutics, GenScript, Merck, CRISPR Therapeutics, Mirus Bio, Integrated DNA Technologies (IDT), Takara Bio, Caribou Biosciences, GeneCopoeia.
|
Key Segments
|
By Type
Genome Editing Genetic engineering gRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering
By Applications
Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes
|